• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: Human cytomegalovirus immunoglobulin
Date Designated: 12/20/2006
Orphan Designation: Prevention of congenital cytomegalovirus (CMV) infection following primary CMV infection in pregnant women
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Biotest Pharmaceuticals Corporation's (BPC)
901 Yamato Road
Suite 101
Boca Raton, Florida 33431
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-